Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
Janus激酶抑制剂托法替尼治疗系统性红斑狼疮的1期双盲随机安全性试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-021-23361-z
Hasni, Sarfaraz A; Gupta, Sarthak; Davis, Michael; Poncio, Elaine; Temesgen-Oyelakin, Yenealem; Carlucci, Philip M; Wang, Xinghao; Naqi, Mohammad; Playford, Martin P; Goel, Rishi R; Li, Xiaobai; Biehl, Ann J; Ochoa-Navas, Isabel; Manna, Zerai; Shi, Yinghui; Thomas, Donald; Chen, Jinguo; Biancotto, Angélique; Apps, Richard; Cheung, Foo; Kotliarov, Yuri; Babyak, Ashley L; Zhou, Huizhi; Shi, Rongye; Stagliano, Katie; Tsai, Wanxia Li; Vian, Laura; Gazaniga, Nathalia; Giudice, Valentina; Lu, Shajia; Brooks, Stephen R; MacKay, Meggan; Gregersen, Peter; Mehta, Nehal N; Remaley, Alan T; Diamond, Betty; O'Shea, John J; Gadina, Massimo; Kaplan, Mariana J